Interviews

Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.

“There is need for additional support to keep the patient engaged and empowered to take ownership and an active role in their health care. I think digital therapeutics are a way to start to bridge that gap where we can have that continuous...

“Even a small improvement on engagement translates into huge impacts on outcomes and satisfaction, which also means cost savings for the whole industry,” says Jason Burum, general manager, Provider Segment, Clinical Effectiveness, Wolters...

John Fryer, president, Tribus, and senior vice president of national markets, Lumeris, offers insight into challenges providers have come up against when switching from fee-for-service to value-based payment models and shares how accelerated...

Morris Panner, JD, president, Intelerad, discusses the mammography and lung cancer diagnostics markets, as well as the effect of technology expansions on care from both patient and payer perspectives.